MedTrace Logo

Indicators of Operative and Postoperative Complications in Patients Operated for Hip Fracture

NCT01294930 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2013-02-21

No results posted yet for this study

Summary

Patients operated for hip fractures are older and have several conditions that have negative influences on the perioperative and postoperative prognosis.

Hip fractures can also be painful, which is stressful for the physiology of the patient. Many old patients have received to little fluid intake. They often have diuretic therapy, which even worsens dehydration/hypovolemia.

Some patients have to wait several days for surgery. Several studies have shown a high degree of complications and an increased mortality in this patient group.

Early preoperative optimization can improve the outcome. The available methods for optimization of the patient are complicated and time consuming.

The investigators wish with this study to try new approaches to find which patients still are dehydrated when they come to the operation ward.

The aim is to measure the color and density of the urine as well as to register the the variability in the plethysmographic curve before spinal anaesthesia.

These results will be compared to circulatory instability during and after surgery as well as to postoperative complications.

Conditions

  • Hip Fracture

Interventions

OTHER

Urine density

measurement of urine color, density and plethysmographic variability index before and during surgery.

Sponsors & Collaborators

  • Vrinnevi Hospital

    collaborator OTHER

  • University Hospital, Linkoeping

    lead OTHER

Principal Investigators

  • Robert Hahn, MD PhD Prof · University Hospital, Linkoeping

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01294930 on ClinicalTrials.gov